ctrl K

Watchlist Price Alert

Scinai Immunotherapeutics... (SCNI)

NASDAQ: SCNI · Real-Time Price · USD

2.54

-0.71 (-21.85%)

At close: Jun 06, 2025, 3:59 PM

2.49

-1.97%

After-hours: Jun 06, 2025, 05:46 PM EDT

Scinai Immunotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-9.71M	-11.06M	-10.87M	2.28M	-22.69M	-20.61M	-6.8M	-3.09M
Interest Income	122.68K	8.1M	928.76	-9.71K	8.3K	1.35M	5.04K	14.38K
Pretax Income	-6.5M	-5.8M	-8.21M	-1.39M	-31.62M	-23.46M	-9.93M	-2.38M
Net Income	-6.5M	-5.8M	-8.21M	-1.39M	-31.62M	-23.46M	-9.93M	-2.38M
Selling & General & Admin	4.5M	5.3M	7.63M	5.19M	2.81M	1.38M	1.4M	1.07M
Research & Development	5.21M	5.76M	3.25M	16.01M	19.88M	19.27M	5.58M	2.44M
Other Expenses	n/a	n/a	n/a	-23.49M	n/a	-38.24K	-185.65K	-416.06K
Operating Expenses	9.71M	11.06M	10.87M	-2.28M	22.69M	20.61M	6.8M	3.09M
Interest Expense	-317	5.05M	-3.15M	338.76K	4.28M	3.78M	-129.95	100.00
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.71M	11.06M	10.87M	-2.28M	22.69M	20.61M	6.8M	3.09M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	976.00	471.00	352.00	277.00	204.00	163.00	125.00	84.00
Shares Outstanding (Diluted)	976.00	471.00	352.00	277.00	204.00	163.00	125.00	84.00
EPS (Basic)	-6.66K	-12.3K	-23.26K	-5K	-154.88K	-143.58K	-79.03K	-28.23K
EPS (Diluted)	-6.66K	-12.3K	-23.26K	-5K	-154.88K	-143.58K	-79.03K	-28.23K
EBITDA	-9.19M	-10.5M	-10.39M	2.75M	-22.21M	-20.54M	-6.67M	-2.93M
EBIT	-9.71M	-11.06M	-10.86M	2.28M	-22.69M	-20.61M	-6.8M	-3.09M
Depreciation & Amortization	514K	562K	471K	468.56K	461.69K	69.53K	123.55K	162.32K